N-(3-Fluorophenyl)piperidin-4-amine hydrochloride, 95.0%, 1g

4'-methyl-2-thiomorpholinomethyl benzophenone, 97.0%, 1g

Benzimidazole-2-carboxylic acid ethyl ester, 97.0%, 5g

(+)-camphre, min 98%, 250 g, emballage plastique.

4,7-Dibromo-2,1,3-benzothiadiazole, 95.0%, 5g

Cuves à usage unique fluorescence UV-transparent, 500 pièce(s)

1-(4-Aminophenyl)cyclopropanecarbonitrile, 97.0%, 100mg

Diethyl 2-((2-ethoxy-2-oxoethyl)thio)succinate, 95%, 500mg

Solution de modification de la matrice de nitrate de palladium, 5 g/l Pd(NO3)2 (99,999 %) dans 1 % HNO3

tert-Butyl (1,1-dimethyl-2-oxoethyl)carbamate, 95.0%, 50mg

2-chloroimidazo[1,2-a]pyridine-3-carbonitrile, 95%, 5g

5-BROMO-2-HYDROXY-4-METHYLNICOTINONITRILE, 95.0%, 250mg

2-Fluorophenyl cyclopentyl ketone, 95.0%, 25g